Hypha are looking forward to presenting two posters at the ISSX meeting held in Portland US from 28th to 31st July 2019.
One is a joint poster with Cyclerion Therapeutics on “Use of Microbial Biotransformation to Produce Scalable Quantities of a Glucuronidated Metabolite of the Clinical Stage Soluble Guanylate Cyclase Stimulator Praliciguat” (P10).
Our other poster illustrating the utility of Hypha’s PolyCYPs enzymes, is on “Accessing Mammalian Drug Metabolites using PolyCYPs Enzymes” (P25)
